Pyxis Oncology Alternatives & Competitors
12 companies similar to Pyxis Oncology — Charting a course to therapeutics for difficult-to-treat cancer.
Companies similar to Pyxis Oncology
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
Genmab
Differentiated human antibody therapeutics for the treatment of cancer
Denmark
Rival Readout
Competing with Pyxis Oncology? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Bolt Biotherapeutics, Inc.
Plans to develop a novel format for T-cell mediated anti-tumour therapy
Redwood City, United Stat...
Germany
ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
Toronto, Canada
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Novelogics Biotechnology Inc.
Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer us...
Canada
Aulos Bioscience
We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immune...
Larkspur, United States
ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, a...
About Pyxis Oncology
Pyxis Oncology, founded in 2019, is a biotech innovator based in the United States, focused on transformative cancer therapies. With a mission expressed through their slogan, "Charting a course to therapeutics for difficult-to-treat cancer," Pyxis aims to change the landscape of cancer treatment. The company is leverag...
development of antibody-drug conjugates, immunotherapy research, clinical program management, oncology-focused drug development
patients with difficult-to-treat cancers, healthcare professionals, oncologists, medical researchers
Antibody-Drug Conjugates, Immunotherapy, Cancer Treatment, Biologics, Tumor Targeting, Immune Suppression Overcoming, Tumor Antigen-Specific TILs, Tumor-Infiltrating Lymphocytes, Cold Tumors, Hot Tumors, Tumor Cell Signaling, Antibody-Based Immunotherapies, Oncology Innovation, Therapeutic Development
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Pyxis Oncology: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Pyxis Oncology on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 25 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
